Keyphrases
Ornithine Decarboxylase
100%
Antizyme
92%
Overexpressing
23%
Tumor
15%
Cyclin D1 (CCND1)
15%
Decarboxylase Activity
15%
PI3 Kinase Signaling
15%
Oncogenic Ras
7%
Hyperplasia
7%
Tumor Development
7%
Tumor Formation
7%
Transformed Cells
7%
Transgenic Lines
7%
Deregulation
7%
Difluoromethylornithine
7%
Effector Pathways
7%
Transgenic Mice
7%
Apoptosis
7%
Overexpression
7%
Constitutively Active
7%
Keratinocytes
7%
Cell Cycle Progression
7%
Inactivator
7%
Active Form
7%
Cell Proliferation
7%
Cell Cycle Control
7%
Tumorigenesis
7%
Hyperproliferation
7%
Cell Cycle Proteins
7%
Post-transcriptional
7%
Epithelial Cells
7%
Tumor Growth
7%
Translational Regulation
7%
Signaling Cascades
7%
Direct Interaction
7%
Oncogenesis
7%
Chemoprevention
7%
Skin Carcinogenesis
7%
Spontaneous Tumors
7%
Two-stage Model
7%
MEK-ERK Pathway
7%
Biochemistry, Genetics and Molecular Biology
Ornithine Decarboxylase
100%
Carcinogenesis
38%
Promoter Region
15%
Phosphoinositide 3-Kinase
15%
Carboxy-Lyases
15%
Cyclin D1
15%
Keratinocyte
7%
Tumor Progression
7%
Transgenics
7%
Cell Proliferation
7%
Cell Cycle Regulation
7%
Cell Cycle Protein
7%
Transgenic Mouse
7%
Translational Regulation
7%
Cell Cycle Progression
7%
RNA
7%
Target Cell
7%
Programmed Cell Death
7%
Protein Kinase B
7%
Neuroscience
Ornithine Decarboxylase
100%
Carcinogenesis
38%
Carboxy-Lyases
15%
Phosphoinositide 3-Kinase
15%
Promoter Region
15%
Cyclin D1
15%
Keratinocyte
7%
Epithelial Cells
7%
Cell Proliferation
7%
Translational Regulation
7%
Hyperplasia
7%
Cell Cycle Regulation
7%
Eflornithine
7%
Cell Cycle Progression
7%
Programmed Cell Death
7%
Cell Cycle Protein
7%